Beizray
Beizray ingredients
| Active ingredient | Strength |
|---|---|
| Docetaxel Anhydrous | 20 mg/mL |
What Beizray is used for
The FDA lists the approved uses on the official label (below). In the EU, docetaxel is approved as Taxotere for:
Breast cancer Taxotere in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with: operable node-positive breast cancer; operable node-negative breast cancer. For patients with operable node-negative breast cancer, adjuvant treatment should be restricted to patients eligible to receive chemotherapy according to internationally established criteria for primary therapy of early breast cancer. Taxotere in combination with doxorubicin is indicated for the treatment of patients with locally advanced or metastatic breast cancer who have not previously received cytotoxic therapy for this condition. Taxotere monotherapy is indicated for the treatment of patients with locally advanced ormetastatic breast cancer after failure of cytotoxic therapy. Previous chemotherapy should have included an anthracycline or an alkylating agent. Taxotere in combi…
EU wording from the European Medicines Agency; US approved uses can differ.
Key facts
- Brand
- Beizray
- Generic name
- Docetaxel
- Made by
- Zhuhai Beihai Biotech Co., Ltd.
- Forms
- Injection, Solution
- Given
- Intravenous
- Drug class
- Microtubule Inhibitor
- FDA approval
- New drug application (NDA) NDA218711
- On the US market since
- 2024
Official information
- MedlinePlus drug information (search for Docetaxel)
In India
- Docetaxel anhydrous: 121 brands in India
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Beizray?
Beizray (Docetaxel) is a cancer medicine made by Zhuhai Beihai Biotech Co., Ltd., approved by the US FDA.
What are the ingredients of Beizray?
Beizray contains Docetaxel Anhydrous (20 mg/mL).
Is Beizray approved in Europe?
The same active substance is approved in the EU as Taxotere.
From the FDA National Drug Code directory (open.fda.gov, public domain) and the European Medicines Agency medicines list. Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA